Simplex Trading’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130K | Buy |
24,789
+18,512
| +295% | +$93.3K | ﹤0.01% | 5243 |
|
|
2026
Q1 | $23.4K | Buy |
6,277
+4,949
| +373% | +$34.2K | ﹤0.01% | 6646 |
|
|
2025
Q4 | $10.9K | Sell |
1,328
-2,069
| -61% | -$15.3K | ﹤0.01% | 6934 |
|
|
2025
Q3 | $25K | Buy |
+3,397
| New | +$25.7K | ﹤0.01% | 7139 |
|
|
2024
Q4 | – | Sell |
-5,071
| Closed | -$32.4K | – | 9134 |
|
|
2024
Q3 | $25K | Buy |
5,071
+708
| +16% | +$3.7K | ﹤0.01% | 6501 |
|
|
2024
Q2 | $22K | Buy |
4,363
+1,250
| +40% | +$7.4K | ﹤0.01% | 6807 |
|
|
2024
Q1 | $16K | Sell |
3,113
-1,542
| -33% | -$11K | ﹤0.01% | 7270 |
|
|
2023
Q4 | $28K | Sell |
4,655
-60,053
| -93% | -$417K | ﹤0.01% | 6629 |
|
|
2023
Q3 | $488K | Buy |
64,708
+9,434
| +17% | +$86.2K | ﹤0.01% | 3426 |
|
|
2023
Q2 | $534K | Buy |
55,274
+5,873
| +12% | +$35.9K | ﹤0.01% | 3241 |
|
|
2023
Q1 | $186K | Buy |
49,401
+38,527
| +354% | +$215K | ﹤0.01% | 4413 |
|
|
2022
Q4 | $70K | Buy |
10,874
+8,440
| +347% | +$69.6K | ﹤0.01% | 5473 |
|
|
2022
Q3 | $21K | Sell |
2,434
-1,586
| -39% | -$16.1K | ﹤0.01% | 7467 |
|
|
2022
Q2 | $40K | Buy |
4,020
+3,109
| +341% | +$30.8K | ﹤0.01% | 6769 |
|
|
2022
Q1 | $10K | Buy |
911
+879
| +2,747% | +$9.79K | ﹤0.01% | 8870 |
|
|
2021
Q4 | $0 | Sell |
32
-387
| -92% | -$3.76K | ﹤0.01% | 10971 |
|
|
2021
Q3 | $4K | Sell |
419
-200
| -32% | -$2.18K | ﹤0.01% | 9350 |
|
|
2021
Q2 | $6K | Buy |
+619
| New | +$7.13K | ﹤0.01% | 9379 |
|
|
2021
Q1 | – | Sell |
-97
| Closed | -$1.09K | – | 9449 |
|
|
2020
Q4 | $1K | Sell |
97
-3,949
| -98% | -$40.8K | ﹤0.01% | 8121 |
|
|
2020
Q3 | $39K | Buy |
4,046
+3,568
| +746% | +$34K | ﹤0.01% | 5842 |
|
|
2020
Q2 | $3K | Buy |
+478
| New | +$4.93K | ﹤0.01% | 7155 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$3K | – | 7473 |
|
|
2019
Q1 | $3K | Sell |
300
-140
| -32% | -$1.71K | ﹤0.01% | 6665 |
|
|
2018
Q4 | $5K | Buy |
440
+205
| +87% | +$2.81K | ﹤0.01% | 6213 |
|
|
2018
Q3 | $3K | Buy |
+235
| New | +$3.25K | ﹤0.01% | 6966 |
|
|
2018
Q2 | – | Sell |
-23,176
| Closed | -$302K | – | 7648 |
|
|
2018
Q1 | $302K | Buy |
23,176
+23,020
| +14,756% | +$302K | 0.01% | 985 |
|
|
2017
Q4 | $1K | Buy |
+156
| New | +$1.97K | ﹤0.01% | 5551 |
|
|
2017
Q1 | – | Sell |
-394
| Closed | -$5K | – | 6472 |
|
|
2016
Q4 | $5K | Buy |
+394
| New | +$5.46K | ﹤0.01% | 4353 |
|
Other funds holding LFCR
WC
LPAM
GRIM
3C
QOP
Simplex Trading's LFCR Position: Q2 2026 in Review
Simplex Trading increased its Lifecore Biomedical (LFCR) stake by 295% in Q2 2026, buying an estimated $93.3K and bringing the position to 24,789 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #5243.
Simplex Trading first reported a position in LFCR in Q4 2016 and has held it in 27 quarters since. The position peaked at $534K in Q2 2023. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.
- Simplex Trading held 24,789 shares of Lifecore Biomedical worth $130K as of Q2 2026.
- Simplex Trading bought 18,512 Lifecore Biomedical shares in Q2 2026, an estimated $93.3K.
- Lifecore Biomedical made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5243 holding.
- Simplex Trading first reported a position in Lifecore Biomedical in Q4 2016 and has held it in 27 quarters since.
- Simplex Trading's Lifecore Biomedical position peaked at $534K in Q2 2023.
- 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.